# Food and Drug Administration Research (93.103)

Source: https://welltoldgrants.com/programs/93-103-food-and-drug-administration-research/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Food and Drug Administration Research is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $1.2 billion in 940 grants, about $1.3 million per award.

## Objectives

To assist institutions and organizations, to establish, expand, and improve research, demonstration, education and information dissemination activities; acquired immunodeficiency syndrome (AIDS), biologics, blood and blood products, therapeutics, vaccines and allergenic projects; drug hazards, human and veterinary drugs, clinical trials on drugs and devices for orphan products development; nutrition, sanitation and microbiological hazards; medical devices and diagnostic products, radiation emitting devices and materials; food safety and food additives. These programs are supported directly or indirectly by the following Centers and Offices: Center for Biologics Evaluation and Research (CBER); Center for Drug Evaluation and Research (CDER); Center for Devices and Radiological Health (CDRH); Center for Veterinary Medicine (CVM), Center for Food Safety and Applied Nutrition (CFSAN), National Center for Toxicological Research (NCTR), the Office of Orphan Products Development (OPD), the Center for Tobacco Products (CTP), and Office of Regulatory Affairs (ORA), and the Office of the Commissioner (OC). Small Business Innovation Research (SBIR) Programs: to stimulate technological innovation; to encourage the role of small business to meet Federal research and development needs; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation by minority and disadvantaged persons in technological innovation. Funding support for scientific conferences that are relevant to the FDA scientific mission and public health are also available.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $203 million | 378 |
| 2022 | $244 million | 433 |
| 2023 | $270 million | 487 |
| 2024 | $251 million | 462 |
| 2025 | $213 million | 423 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| The Critical Path Institute | Arizona | $94.0 million |
| National Environmental Health Association | Colorado | $55.4 million |
| Association of Food & Drug Officials | Pennsylvania | $50.3 million |
| The Medical Device Innovation Consortium | Virginia | $48.6 million |
| Duke University | North Carolina | $35.6 million |
| The Regents of the University of California, San Francisco | California | $25.5 million |
| California Department of Food & Agriculture | California | $22.4 million |
| University of Maryland, College Park | Maryland | $20.4 million |
| University of Maryland, Baltimore | Maryland | $20.2 million |
| Illinois Institute of Technology | Illinois | $17.6 million |
| Regents of the University of Minnesota | Minnesota | $17.6 million |
| University of North Carolina at Chapel Hill | North Carolina | $15.4 million |
| Yale Univ | Connecticut | $14.4 million |
| University of California, Davis | California | $14.0 million |
| The University of Mississippi | Mississippi | $13.9 million |
| Michigan Department of Agriculture and Rural Development | Michigan | $11.8 million |
| World Health Organization, Somalia |  | $11.7 million |
| Reagan-Udall Foundation for the Food and Drug Administration, Inc. | District of Columbia | $11.2 million |
| Baylor College of Medicine | Texas | $11.2 million |
| Department of Agriculture & Consumer Services Florida | Florida | $10.8 million |

## Open opportunities

- [Minor Use Minor Species Development of Drugs (R01)](https://welltoldgrants.com/grants/par-24-216-minor-use-minor-species-development-of-drugs-r01/), closes January 29, 2027
- [Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed](https://welltoldgrants.com/grants/par-25-003-animal-food-regulatory-program-standards-implementation/), closes April 1, 2027
- [NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens](https://welltoldgrants.com/grants/par-25-014-narms-cooperative-agreement-program-to-strengthen/), closes April 1, 2027
- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [Laboratory Flexible Funding Model (LFFM)](https://welltoldgrants.com/grants/rfa-fd-25-007-laboratory-flexible-funding-model-lffm/), closes January 11, 2028
- [Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)](https://welltoldgrants.com/grants/rfa-fd-25-017-reissue-of-rfa-fd-22-001-efficient-and/), closes February 8, 2028
- [Animal and Veterinary Innovation Centers (U18)](https://welltoldgrants.com/grants/par-24-251-animal-and-veterinary-innovation-centers-u18/), closes May 12, 2028
- [Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)](https://welltoldgrants.com/grants/rfa-fd-25-020-reissue-of-rfa-fd-23-001-clinical-studies/), closes May 16, 2028
- [Vet-LIRN Capacity-Building Project and Equipment Grants (U18)](https://welltoldgrants.com/grants/par-23-202-vet-lirn-capacity-building-project-and-equipment-grants/), closes September 4, 2028
- [Development and Maintenance of Human and Animal Food Rapid Response Teams](https://welltoldgrants.com/grants/par-27-014-development-and-maintenance-of-human-and-animal-food/), closes not stated
- [National Produce Safety Partnership Program](https://welltoldgrants.com/grants/par-27-010-national-produce-safety-partnership-program/), closes not stated
- [Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs](https://welltoldgrants.com/grants/par-27-017-flexible-funding-model-advancing-domestic-mutual-reliance/), closes not stated
- [African Medical Devices Regulatory Harmonization Program](https://welltoldgrants.com/grants/for-fd-23-012-african-medical-devices-regulatory-harmonization-program/), closes not stated
- [Manufactured Foods Flexible Funding Model (MF-FFM)](https://welltoldgrants.com/grants/for-fd-23-014-manufactured-foods-flexible-funding-model-mf-ffm/), closes not stated
- [Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-24-001-integrating-machine-learning-with-computational-fluid/), closes not stated
- [Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional](https://welltoldgrants.com/grants/for-fd-24-002-developing-pbpk-model-based-mechanistic-ivivcs-for-long/), closes not stated
- [Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed](https://welltoldgrants.com/grants/for-fd-24-003-utilizing-real-world-data-and-algorithmic-analyses-to/), closes not stated
- [Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)](https://welltoldgrants.com/grants/for-fd-24-004-evaluating-the-cutaneous-pharmacokinetics-of-topical-drug/), closes not stated
- [Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional](https://welltoldgrants.com/grants/for-fd-24-005-improving-predictability-of-food-drug-and-drug-drug/), closes not stated
- [Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed](https://welltoldgrants.com/grants/for-fd-24-006-identification-of-drug-related-and-formulation-related/), closes not stated
- [Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed](https://welltoldgrants.com/grants/for-fd-24-007-synthesis-and-biological-activity-assessment-of-different/), closes not stated
- [Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)](https://welltoldgrants.com/grants/for-fd-24-008-identification-and-evaluation-of-possible-approaches-to/), closes not stated
- [Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-24-009-flexible-funding-model-infrastructure-development-and/), closes not stated
- [Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)](https://welltoldgrants.com/grants/for-fd-24-010-cooperative-agreement-to-support-a-human-abuse-potential/), closes not stated
- [Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed](https://welltoldgrants.com/grants/for-fd-24-011-cooperative-agreement-for-long-term-data-collection-on/), closes not stated
- [Critical Path Public Private Partnerships Clinical Trials Optional](https://welltoldgrants.com/grants/for-fd-24-012-critical-path-public-private-partnerships-clinical-trials/), closes not stated
- [Minor Use Minor Species Development of Drugs (R01)](https://welltoldgrants.com/grants/for-fd-24-013-minor-use-minor-species-development-of-drugs-r01/), closes not stated
- [Collaborations to Enhance Drug Development and Regulatory Science](https://welltoldgrants.com/grants/for-fd-24-014-collaborations-to-enhance-drug-development-and-regulatory/), closes not stated
- [Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-24-015-development-and-maintenance-of-human-and-animal-food/), closes not stated
- [FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-24-016-fda-omhhe-health-equity-innovation-award-enhance-equity/), closes not stated
- [OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-24-017-omhhe-educational-funding-opportunity-expanding-education/), closes not stated
- [Animal Food Regulatory Program Alliance](https://welltoldgrants.com/grants/for-fd-25-002-animal-food-regulatory-program-alliance/), closes not stated
- [Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives](https://welltoldgrants.com/grants/for-fd-25-003-animal-food-regulatory-program-standards-implementation/), closes not stated
- [Center for Research on Complex Generics (U18) Clinical Trials Optional](https://welltoldgrants.com/grants/for-fd-25-004-center-for-research-on-complex-generics-u18-clinical/), closes not stated
- [Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center](https://welltoldgrants.com/grants/for-fd-25-005-integrated-food-safety-system-regulatory-and-laboratory/), closes not stated
- [Studies Addressing Rare Neurodegenerative Diseases including ALS](https://welltoldgrants.com/grants/for-fd-25-006-studies-addressing-rare-neurodegenerative-diseases/), closes not stated
- [Retail Food Safety Regulatory Association Collaboration CAP](https://welltoldgrants.com/grants/for-fd-25-008-retail-food-safety-regulatory-association-collaboration-cap/), closes not stated
- [Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed](https://welltoldgrants.com/grants/for-fd-25-009-cooperative-agreement-to-support-activities-related-to/), closes not stated
- [Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines](https://welltoldgrants.com/grants/for-fd-25-010-cooperative-agreement-to-support-effective-dissemination-of/), closes not stated
- [Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-25-011-health-equity-innovation-award-enhance-equity-funding/), closes not stated
- [REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional](https://welltoldgrants.com/grants/for-fd-25-012-reaching-communities-reach-consortium-u01-clinical-trials/), closes not stated
- [Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed](https://welltoldgrants.com/grants/for-fd-25-013-educational-funding-opportunity-expanding-education-on-skin/), closes not stated
- [Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required](https://welltoldgrants.com/grants/for-fd-25-001-clinical-trials-addressing-unmet-needs-of-rare/), closes not stated
- [NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens](https://welltoldgrants.com/grants/for-fd-25-014-narms-cooperative-agreement-program-to-strengthen/), closes not stated
- [Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics](https://welltoldgrants.com/grants/for-fd-25-015-applied-regulatory-science-research-to-evaluate-and-treat/), closes not stated
- [Food Safety Capacity and Infrastructure Building (U2F)](https://welltoldgrants.com/grants/for-fd-25-019-food-safety-capacity-and-infrastructure-building-u2f/), closes not stated
- [Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)](https://welltoldgrants.com/grants/for-fd-25-017-efficient-and-innovative-natural-history-studies-addressing/), closes not stated
- [Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)](https://welltoldgrants.com/grants/for-fd-25-020-clinical-studies-of-orphan-products-addressing-unmet-needs/), closes not stated
- [Conformance with the Egg Regulatory Program Standards](https://welltoldgrants.com/grants/for-fd-25-021-conformance-with-the-egg-regulatory-program-standards/), closes not stated
- [FDA's Integrated Food Safety System Training Delivery and Development](https://welltoldgrants.com/grants/for-fd-25-016-fda-s-integrated-food-safety-system-training-delivery/), closes not stated
- [Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs](https://welltoldgrants.com/grants/for-fd-25-022-federal-and-state-integration-activities-to-advance/), closes not stated
- [Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities](https://welltoldgrants.com/grants/for-fd-25-023-reducing-fraud-and-lowering-barriers-to-the-production/), closes not stated
- [Retail Food Safety Regulatory Association Collaboration](https://welltoldgrants.com/grants/for-fd-26-003-retail-food-safety-regulatory-association-collaboration/), closes not stated
- [Novel approaches to support therapeutic development in ultra-rare cancers](https://welltoldgrants.com/grants/for-fd-26-004-novel-approaches-to-support-therapeutic-development-in-ultra/), closes not stated